Global Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

Global Stents Market, By Product Type

The Global Stents Market has been segmented by Product Type into Vascular stents and Non-vascular stents.

One major category within this market is vascular stents, which are designed to treat narrow or weakened arteries and veins. These stents are commonly used in the treatment of coronary artery disease, peripheral artery disease, and other vascular conditions. Vascular stents come in different types, including bare metal stents, drug-eluting stents, and bioresorbable stents, each offering unique benefits and applications. The growing prevalence of cardiovascular diseases, coupled with advancements in stent technology and minimally invasive procedures, is driving the expansion of the vascular stents market worldwide.

In addition to vascular stents, the global stents market also includes non-vascular stents, which are used in various anatomical structures outside the vascular system. Non-vascular stents are utilized in the treatment of gastrointestinal, urological, and respiratory conditions, among others. These stents serve diverse purposes, such as relieving obstructions, providing structural support, and facilitating drainage in different organ systems. With the increasing incidence of diseases affecting non-vascular structures and the rising demand for minimally invasive treatment options, the non-vascular stents market is experiencing steady growth. Innovations in stent design, materials, and delivery systems continue to enhance the efficacy and safety of non-vascular stents, driving further market expansion and improving patient outcomes across different medical specialties.

Global Stents Market, By Material

The Global Stents Market has been segmented by Material into Metal and Polymer.

Metal stents, typically made from materials like stainless steel, cobalt-chromium, or nickel-titanium alloys, have long been the standard choice for cardiovascular interventions due to their durability and radial strength. These stents provide excellent scaffolding support to keep blood vessels open, promoting improved blood flow and reducing the risk of restenosis. Concerns have arisen regarding the potential for metal stents to cause inflammation or late complications, leading to the development of alternative materials.

Polymer stents have emerged as a promising alternative, offering unique advantages such as flexibility, biocompatibility, and the potential for drug elution. These stents, often made from biodegradable polymers, gradually degrade over time, allowing the vessel to regain its natural function. Polymer stents can be coated with drugs to prevent restenosis or promote endothelialization, enhancing long-term outcomes for patients. As the stent market continues to evolve, the choice between metal and polymer materials reflects a balance between durability and biocompatibility, with both options contributing to advancements in cardiovascular care and treatment outcomes.

Global Stents Market, By Type

The Global Stents Market has been segmented by Type into Self-expandable Stents and Balloon-expandable Stents.

Self-expandable stents, characterized by their ability to expand without the need for external force, offer flexibility and adaptability, making them suitable for use in tortuous or complex anatomies. These stents are often deployed in regions such as the peripheral arteries or the biliary and gastrointestinal tracts, where precise positioning and conformability to vessel contours are essential for optimal treatment outcomes. Balloon-expandable stents are designed to be deployed using balloon angioplasty techniques, where the stent is mounted on a balloon catheter and expanded by inflation with a balloon. This type of stent provides controlled and predictable expansion, making it particularly suitable for use in coronary arteries, where precise placement and uniform expansion are critical for restoring blood flow and maintaining vessel patency.

The segmentation of the Global Stents Market by type underscores the importance of offering diverse treatment options to address the varying clinical needs and anatomical considerations of patients with cardiovascular diseases. Both self-expandable and balloon-expandable stents play pivotal roles in interventional cardiology and endovascular procedures, offering physicians the flexibility to choose the most appropriate stent design based on individual patient characteristics and lesion characteristics. As advancements in stent technology continue to drive innovation in the field, the Global Stents Market is expected to witness sustained growth, driven by factors such as rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and expanding healthcare infrastructure in emerging markets.

Drivers

• High demand for coronary interventions
• Increasing number of angioplasty procedures
• Emergence of drug-eluting stents

• Advancements in stent technology - Advancements in stent technology have revolutionized the field of cardiovascular intervention by offering more effective and versatile treatment options. Innovations such as drug-eluting stents, bioresorbable scaffolds, and novel coating materials have significantly improved the performance and longevity of stents. Drug-eluting stents, for example, release medication to prevent restenosis, reducing the risk of recurrent blockages in the treated arteries. Bioresorbable scaffolds gradually dissolve over time, allowing the artery to regain its natural function.
  
  Advances in stent design, such as thinner struts and improved flexibility, enhance deliverability and conformability to complex vessel anatomy, enabling safer and more precise placement of stents. These technological breakthroughs have led to better clinical outcomes, reduced rates of complications, and improved patient satisfaction, making stent procedures more widely accessible and effective in managing coronary artery disease and other cardiovascular conditions.

Restraints

• Challenges in addressing complex lesions
• Potential for stent recalls and litigations

• Concerns regarding stent durability - Despite significant advancements, concerns regarding stent durability persist within the medical community and among patients. The long-term durability of stents, particularly drug-eluting stents, remains a topic of debate due to the potential for late thrombosis and stent fracture. While drug-eluting stents effectively inhibit restenosis in the short term, questions arise regarding their performance over extended periods.
  
  Concerns about the mechanical integrity of stents and their ability to withstand physiological forces within the artery raise doubts about their long-term efficacy and safety. The impact of factors such as patient comorbidities, lifestyle habits, and medication adherence on stent durability adds complexity to treatment decision-making and follow-up care. Addressing these concerns requires ongoing research, vigilance in patient monitoring, and continued innovation in stent design to optimize long-term outcomes and ensure patient safety.

Opportunities

• Development of bioresorbable stents
• Integration of digital health technologies
• Focus on preventive cardiology

• Utilization of real-world evidence - The utilization of real-world evidence (RWE) offers valuable insights into the safety, effectiveness, and long-term outcomes of stent procedures in routine clinical practice. RWE encompasses data collected from diverse sources, including electronic health records, registries, and patient-reported outcomes, reflecting real-world treatment patterns and patient experiences. By analyzing RWE, healthcare providers can assess the comparative effectiveness of different stent types, identify patient subgroups that may benefit most from specific interventions, and evaluate the impact of treatment strategies on healthcare outcomes and resource utilization.
  
  RWE facilitates post-market surveillance of stents, enabling the timely detection of safety signals and the refinement of clinical guidelines and best practices. Leveraging RWE in stent research and decision-making processes enhances evidence-based medicine, promotes transparency, and ultimately improves the quality of patient care by informing clinical decision-making and optimizing treatment outcomes.